Indeed, Dai and colleagues investigated the role of the RAS/MEK/ERK pathway in relation to DNA damage in human MM cells exposed to CHK1 inhibitors and found that RAS/MEK/ERK signaling disruption significantly augmented DNA damage induced by CHK1 inhibitors and increased cells’ sensitivity [122]. This evidence concerns the gene MAP2K7 and Miyoshi myopathy.